Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

This publication has 15 references indexed in Scilit:

• Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI
  European Respiratory Journal, 1994
• A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma
  Allergy, 1994
• Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhaler
  Respiratory Medicine, 1993
• Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
  Archives of Disease in Childhood, 1993
• Review papers : The statistical basis of meta-analysis
  Statistical Methods in Medical Research, 1993
• The oral systemic availability of fluticasone propionate in man– preliminary data [letter]
  British Journal of Clinical Pharmacology, 1993
• Inhaled corticosteroids: benefits and risks.
  Thorax, 1992
• Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids
  Respiratory Medicine, 1991
• Structure-activity relationships of topically active steroids: the selection of fluticasone propionate
  Respiratory Medicine, 1990
• The human pharmacology of fluticasone propionate
  Respiratory Medicine, 1990